Final results of the international, expanded-access program of everolimus in patients with advanced renal cell carcinoma who progress after prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy.


Gruenwald V., Karakiewicz P. I., Bavbek S. E., Miller K., Machiels J. H., Lee S., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.29, sa.15, 2011 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 29 Sayı: 15
  • Basım Tarihi: 2011
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • İstanbul Üniversitesi Adresli: Hayır